Covid-19: Promising findings on CoronaVac in new study - but questions remain about Delta variant
The data are based on the inoculation of more than 10 million people in Chile. However, despite having vaccinated more than 70% of its population, the country seeing an increase in cases. The CoronaVac vaccine is 66% effective at preventing symptomatic Covid-19 infection among fully vaccinated adults aged 16 years and older, according to a real-world study published on 7 July in The more promising finding, however, was that the two-dose vaccine showed higher protection against hospitalisation (87.5%), ICU admission (90%); and death (86%) – a finding that is consistent with the results of ...